Total Payments
$6,731
2024 Payments
$274.69
Companies
31
Transactions
386
Medicare Patients
1,391
Medicare Billing
$166,554
Payment Breakdown by Category
Food & Beverage$6,676 (99.2%)
Education$54.89 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,676 | 379 | 99.2% |
| Education | $54.89 | 7 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,780 | 84 | $0 (2022) |
| Novo Nordisk Inc | $1,478 | 90 | $0 (2020) |
| Lilly USA, LLC | $764.62 | 41 | $0 (2024) |
| ABBVIE INC. | $374.54 | 20 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $342.03 | 30 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $331.76 | 22 | $0 (2021) |
| GlaxoSmithKline, LLC. | $211.34 | 15 | $0 (2018) |
| Amgen Inc. | $209.67 | 14 | $0 (2020) |
| Radius Health, Inc. | $201.97 | 6 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $184.94 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $274.69 | 14 | ABBVIE INC. ($252.96) |
| 2023 | $82.77 | 5 | ABBVIE INC. ($53.66) |
| 2022 | $145.54 | 2 | Lilly USA, LLC ($124.78) |
| 2021 | $18.29 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18.29) |
| 2020 | $314.69 | 12 | Radius Health, Inc. ($147.07) |
| 2019 | $1,511 | 87 | Novo Nordisk Inc ($461.21) |
| 2018 | $1,841 | 115 | AstraZeneca Pharmaceuticals LP ($624.30) |
| 2017 | $2,543 | 150 | AstraZeneca Pharmaceuticals LP ($766.96) |
All Payment Transactions
386 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $123.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.53 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Oncology | ||||||
| 04/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Oncology | ||||||
| 11/16/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/27/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.78 | General |
| Category: Diabetes | ||||||
| 12/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: DIABETES | ||||||
| 03/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Diabetes | ||||||
| 02/27/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $106.57 | General |
| Category: Endocrinology | ||||||
| 02/27/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 462 | 713 | $174,150 | $62,037 |
| 2022 | 8 | 358 | 556 | $124,852 | $46,611 |
| 2021 | 7 | 254 | 418 | $81,310 | $33,763 |
| 2020 | 8 | 317 | 439 | $78,722 | $24,143 |
Total Patients
1,391
Total Services
2,126
Medicare Billing
$166,554
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 332 | $83,558 | $25,731 | 30.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 100 | 167 | $42,031 | $13,635 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 92 | 92 | $13,800 | $11,255 | 81.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 58 | 75 | $26,442 | $8,975 | 33.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 27 | 27 | $4,780 | $1,319 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 20 | $3,540 | $1,122 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 302 | $76,007 | $25,740 | 33.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $9,450 | $7,851 | 83.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 42 | 63 | $11,152 | $4,005 | 35.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 34 | 50 | $12,584 | $3,850 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 26 | $9,167 | $3,198 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 28 | $4,957 | $1,293 | 26.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 11 | 12 | $1,295 | $465.60 | 35.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $240.00 | $209.18 | 87.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 200 | $45,137 | $18,787 | 41.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 102 | $14,817 | $6,311 | 42.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 39 | $11,490 | $3,384 | 29.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 14 | 14 | $5,626 | $1,698 | 30.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 25 | 25 | $1,790 | $1,632 | 91.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 12 | 12 | $1,800 | $1,535 | 85.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 26 | 26 | $650.00 | $416.78 | 64.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 141 | 247 | $49,477 | $12,778 | 25.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 54 | 56 | $15,245 | $5,626 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 24 | 24 | $4,700 | $2,517 | 53.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 55 | $6,869 | $1,986 | 28.9% |
About Dr. Debra Higginbotham, MD
Dr. Debra Higginbotham, MD is a Family Medicine healthcare provider based in Santa Fe, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861460446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Higginbotham, MD has received a total of $6,731 in payments from pharmaceutical and medical device companies, with $274.69 received in 2024. These payments were reported across 386 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,676).
As a Medicare-enrolled provider, Higginbotham has provided services to 1,391 Medicare beneficiaries, totaling 2,126 services with total Medicare billing of $166,554. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Santa Fe, NM
- Active Since 03/09/2006
- Last Updated 01/30/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1861460446
Products in Payments
- FARXIGA (Drug) $1,217
- Ozempic (Drug) $501.65
- Victoza (Drug) $437.12
- TRULICITY (Drug) $398.94
- SYMBICORT (Drug) $294.84
- Tresiba (Drug) $286.21
- JARDIANCE (Drug) $257.14
- Tymlos (Biological) $201.97
- QULIPTA (Drug) $174.81
- BEVESPI AEROSPHERE (Drug) $154.93
- MOUNJARO (Drug) $146.51
- JANUVIA (Drug) $138.26
- INVOKANA (Drug) $136.78
- UBRELVY (Drug) $131.81
- ELIQUIS (Drug) $130.80
- Xultophy 100/3.6 (Drug) $106.39
- ANORO (Drug) $97.48
- ASMANEX (Drug) $94.46
- STIOLTO (Drug) $93.46
- SPIRIVA (Drug) $75.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Santa Fe
Dr. Wendy Johnson, Md, MD
Family Medicine — Payments: $53,424
Family Medicine $53,424
Kurt Kastendieck, Md, MD
Family Medicine — Payments: $10,673
Family Medicine $10,673
Lena Bruce, M.d, M.D
Family Medicine — Payments: $10,000
Family Medicine $10,000
Luis Rigales, Md, MD
Family Medicine — Payments: $5,010
Family Medicine $5,010
Dr. Gerzain Chavez, M.d, M.D
Family Medicine — Payments: $4,150
Family Medicine $4,150
Aryan Caire, M.d, M.D
Family Medicine — Payments: $3,516
Family Medicine $3,516